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The autism and schizophrenia associated gene CYFIP1 is
critical for the maintenance of dendritic complexity and the
stabilization of mature spines
M Pathania1, EC Davenport1, J Muir, DF Sheehan, G López-Doménech and JT Kittler
Copy number variation (CNV) at the 15q11.2 region has been identiﬁed as a signiﬁcant risk locus for neurological and
neuropsychiatric conditions such as schizophrenia (SCZ) and autism spectrum disorder (ASD). However, the individual roles for
genes at this locus in nervous system development, function and connectivity remain poorly understood. Haploinsufﬁciency of one
gene in this region, Cyﬁp1, may provide a model for 15q11.2 CNV-associated neuropsychiatric phenotypes. Here we show that
altering CYFIP1 expression levels in neurons both in vitro and in vivo inﬂuences dendritic complexity, spine morphology, spine actin
dynamics and synaptic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor lateral diffusion. CYFIP1 is highly
enriched at synapses and its overexpression in vitro leads to increased dendritic complexity. Neurons derived from Cyﬁp1
heterozygous animals on the other hand, possess reduced dendritic complexity, increased mobile F-actin and enhanced GluA2-
containing AMPA receptor mobility at synapses. Interestingly, Cyﬁp1 overexpression or haploinsufﬁciency increased immature spine
number, whereas activity-dependent changes in spine volume were occluded in Cyﬁp1 haploinsufﬁcient neurons. In vivo, Cyﬁp1
heterozygous animals exhibited deﬁcits in dendritic complexity as well as an altered ratio of immature-to-mature spines in
hippocampal CA1 neurons. In summary, we provide evidence that dysregulation of CYFIP1 expression levels leads to pathological
changes in CNS maturation and neuronal connectivity, both of which may contribute to the development of the neurological
symptoms seen in ASD and SCZ.
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INTRODUCTION
Copy number variations of the 15q11.2 region of the human
genome are implicated in the development of neurological and
neuropsychiatric conditions such as autism spectrum disorder
(ASD), epilepsy, intellectual disability (ID) and schizophrenia
(SCZ).1–7 Copy number variation of one gene within 15q11.2,
coding for the cytoplasmic FMRP-interacting protein 1 (CYFIP1),
has been linked to both ASD and SCZ.5,8,9 Furthermore, genome-
wide expression proﬁling of patients with duplication of 15q11-
–q13 has speciﬁcally demonstrated upregulated Cyﬁp1 mRNA in
those that suffer from ASD.10 Changes in CYFIP1 levels may thus
lead to the neuropsychiatric and cognitive phenotypes associated
with copy number variation at 15q11.2. However, the exact role
that CYFIP1 has in normal nervous system function and
development, and the consequences of its dysregulation, remain
poorly understood.
Dendritic morphogenesis, synaptogenesis and continued
activity-dependent remodelling of synaptic connections are
critical for the development and maintenance of functional
neuronal networks.11–15 A disruption in any of these processes
produces network-wide deﬁcits in neuronal connectivity and may
help explain why changes in morphological complexity, dendritic
spine number, shape and plasticity are associated with several
neuropsychiatric and neurological disorders, including SCZ, ASD,
ID and epilepsy.16–19 Actin cytoskeletal dynamics have a key role
in the establishment and maintenance of both dendritic arboriza-
tions and spines, and are also critical for the structural alterations
in spine shape important for cellular forms of synaptic plasticity,
such as long-term potentiation and long-term depression.20–23
Moreover, alterations in the regulation of actin at dendritic spines,
by neurodevelopmental disease-associated proteins such as
DISC1, DTNBP1, SHANK3, PAK3, Oligophrenin and SRGAP2, have
been shown to produce deﬁcits in both synaptic plasticity and the
formation and consolidation of long-term memories.23–29
One critical modulator of cellular actin dynamics is the
ubiquitous heteropentameric WAVE regulatory complex consist-
ing of the proteins WAVE, Abi, Nap1, HSPC300 and CYFIP1 (also
known as SRA-1) or CYFIP2.30 The main role of CYFIP1 in this
complex is to maintain the WAVE regulatory complex in an
inhibited state until the small GTPase Rac1, once activated, binds
CYFIP1. Rac1 binding results in dissociation of CYFIP1 from the
WAVE regulatory complex, allowing WAVE to activate the actin
nucleator Arp2/3 and subsequently enabling de novo F-actin
assembly.30,31 In this way, CYFIP1 functions as a key, conserved
regulator of actin nucleation in cells.30 Furthermore, CYFIP1
couples actin dynamics to other cellular processes, such as carrier
vesicle biogenesis in the trans-Golgi network, and, via interactions
with the FRMP (Fragile X mental retardation protein), regulates
synaptic mRNA translation in an activity-dependent manner.32,33
However, still very little is known about CYFIP1’s role in establish-
ing or maintaining neuronal connectivity, speciﬁcally its
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involvement in the regulation of dendritic morphology, synaptic
structural plasticity and neurotransmitter receptor mobility.
Furthermore, how both deletions and duplications affecting Cyﬁp1
expression produce similar neuropsychiatric phenotypes has also
not yet been addressed.34,35
Here we show that both CYFIP1 and CYFIP2 are highly enriched
at excitatory synapses in dendritic spines. In dissociated neurons,
overexpression of CYFIP1 or CYFIP2 leads to increased dendritic
complexity and altered spine morphology whereas conversely,
reducing CYFIP1 levels causes decreased dendritic complexity and
an increase in immature dendritic spines. CYFIP1 deﬁciency results
in increased F-actin assembly within dendritic spines, occludes
N-methyl-D-aspartate (NMDA) receptor-induced spine shrinkage
and leads to alterations in the surface dynamics and synaptic
mobility of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors. In vivo, Cyﬁp1 deletion in the mouse leads to
delayed embryonic development and early embryonic death
whereas Cyﬁp1 haploinsufﬁciency causes reduced dendritic
complexity and an increase in immature spines in the hippocam-
pus. Our results support a critical role for CYFIP1 in development,
dendritic morphogenesis and synaptic connectivity and provide
further support for the idea that dysregulated CYFIP1 mediates
the molecular aetiology of 15q11.2 Copy number variation-
associated neuropsychiatric conditions such as ASD, SCZ and
epilepsy.
MATERIALS AND METHODS
Cell culture and transfection
Hippocampal cultures were obtained from E16 mouse embryos (produced
via Cyﬁp1+/+xCyﬁp1+/− crosses) or E18 rat embryos as previously described
and transfected using Lipofectamine-2000 (Life Technologies, Paisley,
UK).36
Microscopy, quantitative analysis of neuronal and dendritic spine
morphology, and ﬂuorescence recovery after photobleaching
(FRAP)
Confocal images were acquired on a Zeiss LSM700 upright confocal
microscope using a 63X oil objective (NA: 1.4) unless otherwise stated (Carl
Zeiss, Welwyn Garden City, UK). Image stacks for dendritic morphological
and spine analysis had voxel dimensions of 0.39 μm×0.39 μm×0.54 μm
and 0.19 μm×0.19 μm×0.57 μm, respectively. Neuronal arbours were
reconstructed and subjected to Sholl analysis, using either Imaris (Bitplane
AG, Zurich, Switzerland) or NeuronStudio and ImageJ (NIH, Bethesda, MD,
USA).37 Spines were manually identiﬁed on 100–200 μm long secondary
dendrites and analyzed for morphological classiﬁcation or volume
measurements in Imaris software (Bitplane). For spine classiﬁcation custom
parameters were used and spines were classiﬁed into stubby, mushroom,
long and thin, and ﬁlopodia categories using a ratio of spine head and
neck diameters to spine length. Classiﬁcation was entirely automated until
the ﬁnal step where errors in classiﬁcation were removed.
Single-plane confocal images were acquired for localization experiments
in vitro. To quantify CYFIP1 and CYFIP2 enrichment at synaptic sites, the
ﬂuorescence intensity of CYFIP1 or CYFIP2 was measured as the average
intensity within the labelled synaptic puncta and normalized to the
average intensity of the total process including synaptic puncta using
Metamorph software (Molecular Devices, Sunnyvale, CA, USA).
Dendritic morphology and spines in P55–60 mice were analysed using
the FD Rapid Golgi Stain kit (FD NeuroTechnologies, Baltimore, MD, USA)
and Neurolucida (MBF Bioscience, Williston, VT, USA). Golgi-impregnated
brains were sliced at 150 μm using a vibratome (Leica Microsystems,
Heerbrugg, Switzerland). Well-isolated hippocampal CA1 neurons were
imaged at 60X using the Neurolucida software system and an upright light
microscope with a motorized stage (MBF Bioscience). The entire extent
(apical and basal) of the dendritic tree was traced and reconstructed. For
spine analysis, two apical oblique and two basal dendrites were quantiﬁed
per cell. Three males were analysed for each condition with a minimum of
three cells traced per animal. When using animals from separate litters,
each genotype was equally represented from each litter.
Chemical long-term depression and ﬂuorescence recovery after photo-
bleaching (FRAP) on actin in dendritic spines was performed as described
previously.38,39 FRAP movies were analysed in ImageJ (NIH) using a
custom-built plugin, curves were ﬁtted using Mathematica (Wolfram
Research, Champaign, IL, USA). For further details see Supplementary
Methods.
Quantum dot (QD) imaging
A total of 12–16DIV hippocampal cells transfected with GluA2SEP were live
imaged under perfusion in ACSF at 37 °C and quantum dot (QD) movies
were recorded at 8.5 Hz. Labelling of GluA2SEP with QDs was performed at
RT using a mouse anti-GFP antibody (10 μgml− 1, Neuromab, N38) and an
anti-mouse 605-nm QD (0.5 nM, Life Technologies). Analysis of QD receptor
dynamics was performed as described (see Supplementary Methods).40
RESULTS
CYFIP1 and CYFIP2 are enriched at excitatory synapses
To explore the localization of CYFIP1 and CYFIP2 in neurons
CYFIP1GFP or CYFIP2GFP (Supplementary Figure 1) were co-
expressed in mature hippocampal neurons with DsRed as a
marker of neuronal morphology and analysed using confocal
microscopy. Compared with the localization of DsRed, which
uniformly ﬁlled both dendritic processes and spines, CYFIP1GFP
and CYFIP2GFP exhibited a nonuniform distribution appearing to
be selectively targeted to punctate clusters in spines and along
dendrites (Figures 1a and b). A similar enrichment in spines was
observed for endogenous CYFIP1 using a CYFIP1-speciﬁc antibody
and actinGFP to label neuronal morphology (Figure 1c;
Supplementary Figure 1). In addition, CYFIP1 is detected within
the post synaptic density fraction by western blotting
(Supplementary Figure 4). Co-expression experiments with
CYFIP1GFP and CYFIP2mCherry revealed that the majority of
CYFIP1GFP co-localized with CYFIP2mCherry and overlapping puncta
were found both in dendritic processes and spines
(Supplementary Figure 2A).
Using immunoﬂuorescence and confocal microscopy, both
CYFIP1GFP and CYFIP2GFP levels were found to be ~ 90% enriched
at Homer and VGLUT-positive excitatory synaptic sites compared
with total dendritic processes (CYFIP1, 91.4 ± 9.8% increase,
Po0.001; CYFIP2, 85.9 ± 12.6% increase, Po0.001; Figures 1d
and e,Supplementary Figure 2B). In addition, endogenous CYFIP1
was also highly enriched at excitatory synapses and co-localized
with the excitatory marker PSD-95 (Figure 1f). Thus endogenous
CYFIP1, along with CYFIP1GFP and CYFIP2GFP, are found at
excitatory synapses and exhibit high levels of expression at sites
of F-actin accumulation, like dendritic spines.
Overexpression of CYFIP1 and CYFIP2 enhances dendritic
complexity and alters dendritic spine morphology
Microduplication of the CYFIP1-encoding region at 15q11.2 is
associated with increased neuropsychiatric disease burden, and
increased expression of CYFIP1 has speciﬁcally been linked to
ASD.1,3,10 Overexpression of CYFIP1GFP or CYFIP2GFP resulted in a
signiﬁcant increase in dendritic complexity as a function of
distance from the soma compared with control neurons expres-
sing GFP, measured using either number of intersections or
number of branch points as indicators of morphological complex-
ity (Figures 2a–c). In addition, total dendritic length and the total
number of branch points per cell were also increased in the
CYFIP1 and CYFIP2 overexpressors (dendritic length: CYFIP1, 37%
increase, 2876 ± 174 μm, Po0.01; CYFIP2, 33% increase,
2787 ± 152 μm, Po0.01; GFP, 2099 ± 163 μm; branch points:
CYFIP1, 48% increase, 66.5 ± 7.0, Po0.05; CYFIP2, 101% increase,
90.1 ± 5.6, Po0.001; GFP 44.8 ± 7.7; Figures 2d and e).
To examine whether changes in dendritic complexity were
accompanied by changes in excitatory spine number or shape, we
measured spines in CYFIP1mCherry+actinGFP-expressing neurons at
21DIV. Compared with DsRed+actinGFP transfected neurons,
Role of CYFIP1 in CNS function
M Pathania et al
2
Translational Psychiatry (2014), 1 – 11 © 2014 Macmillan Publishers Limited
Figure 1. CYFIP1 and CYFIP2 are localized at dendritic spines and enriched at excitatory synapses. In 17–20DIV rat hippocampal neurons,
CYFIP1GFP (a), CYFIP2GFP (b) or endogenous CYFIP1 (c) localize to dendritic spines. DsRed (a, b) or actinGFP (c) were used to label processes. A
line-scan through the dendritic shaft and spine head (right graphs) shows the ﬂuorescence intensity of the green and red channels depicting
the enrichment of CYFIP1GFP, CYFIP2GFP or endogenous CYFIP1 in the spine compared with the dendrite. CYFIP1GFP and CYFIP2GFP clusters co-
localize with the excitatory synaptic marker Homer (d) (arrowheads). Quantiﬁcation shows that there is an enrichment of CYFIP1GFP and
CYFIP2GFP at excitatory synapses compared with the total process (excitatory: CYFIP1 n= 61, CYFIP2 n= 54, ***Po0.001) (e). Endogenous
CYFIP1 also co-localizes with the excitatory synaptic marker PSD-95 (arrowheads) in actinGFP-expressing cells (f). Scale bars, 2 μm.
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CYFIP1mCherry+actinGFP-expressing cells displayed no signiﬁcant
difference in spine density (data not shown). However, CYFIP1
overexpressors had signiﬁcantly fewer stubby spines (30%
decrease in stubby spines, DsRed+actinGFP: 0.32 ± 0.01 spines
μm− 1, CYFIP1mCherry+actinGFP: 0.24 ± 0.01 spines μm− 1, Po0.01)
and increased numbers of long, thin spines and ﬁlopodia (24%
increase in long, thin spines, DsRed+actinGFP: 0.14 ± 0.01 spines
μm− 1, CYFIP1mCherry+actinGFP: 0.17 ± 0.01 spines μm− 1, Po0.05;
145% increase in ﬁlopodia, DsRed+actinGFP: 0.006 ± 0.001 spines
μm− 1, CYFIP1mCherry+actinGFP: 0.016 ± 0.003 spines μm− 1,
Po0.01; Figures 2f and g). Furthermore, spines were signiﬁcantly
longer in CYFIP1 overexpressors regardless of subtype classiﬁca-
tion (DsRed+actinGFP: 1.13 ± 0.005 μm, CYFIP1mCherry+actinGFP:
1.29 ± 0.005 μm, Po0.0001, Figure 2h). CYFIP1 overexpression
also signiﬁcantly decreased spine diameter, whereas spine volume
showed an overall increase due to the dominating effect of the
increase in spine length (Supplementary Figures 6C and D). These
results demonstrate that increasing CYFIP1 expression levels
above baseline enhances dendritic complexity and alters the ratio
of mature versus immature spines in neurons, thereby changing
network connectivity.
CYFIP1 is essential for embryonic development and its loss leads
to marked developmental delay
To study the effects of decreased Cyﬁp1 levels in vivo, we
characterized a Cyﬁp1 KO mouse41 and found that deletion was
embryonically lethal. However, fertilized KO oocytes from
Cyﬁp1+/− × Cyﬁp1+/− crosses did persist up to the blastocyst
stage in vitro (not shown), and in pregnant dams, they were
detectable until embryonic day 8.5 (E8.5) postcoitum
(Supplementary Table 1). At this stage, Cyﬁp1 KO embryos were
Figure 2. CYFIP1 and CYFIP2 promote increased dendritic complexity and altered dendritic spine structure. (a) Overexpression of CYFIP1GFP or
CYFIP2GFP for 4 days results in increased dendritic complexity compared with expression of control GFP in 14DIV rat hippocampal neurons co-
transfected with DsRed. Scale bar, 20 μm. Quantiﬁcation by Sholl analysis shows that number of intersections (b) and number of branch points
(c) are signiﬁcantly increased with distance from the soma in CYFIP1- or CYFIP2-overexpressing neurons compared with GFP control (data
points represent an average of 12–13 cells, *Po0.05). Expression of CYFIP1 or CYFIP2 increases total dendritic length (d) (CYFIP1, n= 13,
**Po0.01, CYFIP2, n= 12, **Po0.01, compared with control n= 13) and number of branch points per cell (e) (CYFIP1, n= 13, *Po0.05, CYFIP2,
n= 12, ***Po0.001, compared with control n= 13). Spine morphology was analysed at 21DIV in CYFIP1mCherry+actinGFP-expressing mouse
hippocampal neurons and compared with DsRed+actinGFP-expressing cells (f) (upper panel: representative image; lower panel: 3D
reconstruction). Scale bar, 5 μm. Colour key for spine type in 3-dimensional reconstruction: green=mushroom, red= stubby, blue= long and
thin, pink= ﬁlipodia. CYFIP1mCherry overexpression resulted in decreased stubby spines and increased long, thin spines and ﬁlopodia (g)
(n= 16–18 cells per condition, *Po0.05, **Po0.01). Spine length is increased across the entire population regardless of subtype classiﬁcation
in CYFIP1-overexpressing neurons compared with control neurons (h) (n= 15 000–19 000 spines per condition, ****Po0.0001).
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signiﬁcantly reduced in size and displayed delayed development
compared with their heterozygous (Cyﬁp1+/−) or wild-type (WT)
counterparts (Supplementary Figures 3A–C). Further examination
revealed complete developmental failure resulting in reduced
body elongation and patterning. Cyﬁp1+/− heterozygous animals
on the other hand, were viable until adulthood, were fertile and
did not show any gross morphological abnormalities in brain
structure when compared with WT (Supplementary Figure 3H).
These data suggest that adequate levels of CYFIP1 are indis-
pensable for proper development through early stages of
embryogenesis.
Cyﬁp1 haploinsufﬁciency results in decreased dendritic complexity
and increased immature spine number
Microdeletion at 15q11.2 renders people haploinsufﬁcient for
Cyﬁp1 and is associated with ASD and SCZ.4,6,7 We therefore
investigated the effects of decreased CYFIP1 levels by measuring
dendritic and spine morphologies in Cyﬁp1+/− hippocampal
neurons (Supplementary Figures 3F and G). Sholl analysis of
14DIV, actinGFP-labelled neurons revealed that reduced CYFIP1
levels had the opposite effect on dendritic complexity to that of
CYFIP1 overexpression, leading to a marked decrease in dendritic
complexity between 30 and 110 μm away from the soma (Figures
3a–c). Furthermore, both total dendritic length and the total
number of branch points were reduced in Cyﬁp1+/− neurons
compared with control (15% decrease in total dendritic length in
Cyﬁp1+/− neurons, WT: 2704 ± 96.8 μm, Cyﬁp1+/−: 2298 ± 80.2 μm,
Po0.01; 20% decrease in number of branch points in Cyﬁp1+/−
neurons, WT: 76.7 ± 4.1, Cyﬁp1+/−: 61.4 ± 3.6, Po0.01; Figures 3d
and e). Spine density was unchanged in Cyﬁp1+/− neurons
compared with WT controls; however, when spines were further
classiﬁed into the different morphological subtypes, long and thin
spines and ﬁlopodia were signiﬁcantly increased (30% increase in
long, thin spines, WT: 0.15 ± 0.01 spines μm− 1, Cyﬁp1+/−:
0.20 ± 0.01 spines μm− 1, Po0.05; 125% increase in ﬁlopodia, WT:
0.007 ± 0.001 spines μm− 1, Cyﬁp1+/−: 0.016 ± 0.003 spines μm− 1,
Po0.05, respectively; Figures 3f–h). In addition, spines were
signiﬁcantly longer in the Cyﬁp1+/− neurons irrespective of
subtype classiﬁcation (WT: 1.14 ± 0.003 μm, Cyﬁp1+/−:
1.27 ± 0.003 μm, Po0.0001, Figure 3i). However, no change in
spine diameter or volume was observed in the Cyﬁp1 haploinsufﬁ-
cient neurons (Supplementary Figures 6A and B). These experi-
ments demonstrate that Cyﬁp1 haploinsufﬁciency results in
decreased dendritic complexity and produces alterations in spine
morphology.
CYFIP1 regulates actin assembly at dendritic spines
CYFIP1 negatively regulates local actin ﬁlament assembly,
suggesting that actin dynamics may be altered in Cyﬁp1+/−
dendritic spines. FRAP of actinGFP in spines of Cyﬁp1+/− neurons
revealed a signiﬁcant difference in amount of ﬂuorescence
recovery compared with WT controls. Fluorescence intensity
within the spine head of WT neurons returned to only
64.1 ± 5.2% of the pre-bleached ﬂuorescence by 40 s compared
with 80.0 ± 4.1% in the Cyﬁp1+/− neurons (Po0.05; Figures 4a and
b). Moreover, the ﬂuorescence recovery of Cyﬁp1+/− neurons
plateaued at a greater intensity than WT neurons, which was
conﬁrmed by a signiﬁcant increase in the total mobile fraction (i.e.
the proportion of ﬁnal recovered ﬂuorescence compared with the
total bleached ﬂuorescence, 16% increase, WT: 68.4 ± 5.46%,
Cyﬁp1+/−: 84.4 ± 3.97%, Po0.05; Figure 4c). However, there was
no change in the recovery rate constant between Cyﬁp1+/− and
WT neurons. Similar results were also obtained using LifeactGFP, an
F-actin-speciﬁc ﬂuorescent probe suitable for FRAP experiments.42
Photobleaching spines expressing LifeactGFP produced a signiﬁ-
cantly greater amount of recovered ﬂuorescence in Cyﬁp1+/−
neurons compared with WT again by 40 s (WT: 67.9 ± 4.8%,
Cyﬁp1+/−: 85.5 ± 7.0%, Po0.05; Figure 4d) resulting in a signiﬁcant
increase in the total mobile fraction (9.8% increase, WT:
70.1 ± 3.03%, Cyﬁp1+/−: 79.9 ± 3.12%, Po0.05; Figure 4e).42,43
Taken together, the increased recovery of actinGFP and LifeactGFP
suggests an increase in F-actin assembly in the Cyﬁp1+/− spines.
Cyﬁp1 haploinsufﬁciency occludes NMDA receptor-dependent
structural plasticity
As Cyﬁp1 haploinsufﬁciency changes actin availability in spines
and alters the ratio of mature versus immature spines at steady-
state, we hypothesised that stimulus-dependent structural plasti-
city would also be altered in Cyﬁp1+/− spines. To study the role
that CYFIP1 has in spines during structural plasticity, we utilized an
established chemical long-term depression protocol.38 Brief bath
application of 20 μM NMDA plus 20 μM glycine induces a 15–20%
spine shrinkage within a timeframe of 40min, which is measured
as a decrease in spine volume without a concomitant change in
either spine diameter or length (Figures 4f and g; Supplementary
Figures 6E and F). Using this stimulus, we were able to induce
spine shrinkage in WT neurons in response to NMDA treatment
(Figures 4f and g). Cumulative frequency curves of spine volume
show a leftward shift following NMDA application in WT neurons,
indicating a reduction of spine volume across the population
(Figure 4h). Cyﬁp1+/− spines showed no change in spine volume
following NMDA application and spine volume remained
unchanged from its basally low levels (16% decrease in WT spine
volume following NMDA treatment, no change in Cyﬁp1+/− spine
volume following NMDA treatment, WT saline: 0.30 ± 0.003 μm3,
WT NMDA: 0.25 ± 0.001 μm3, Cyﬁp1+/− saline: 0.26 ± 0.001 μm3,
Cyﬁp1+/− NMDA: 0.26 ± 0.002 μm3, Po0.0001; Figures 4f–h). These
data reveal a role for CYFIP1 in mediating structural reorganization
during synaptic plasticity, possibly through dynamic regulation of
the local actin cytoskeleton in spines.
Altered surface AMPA receptor mobility due to Cyﬁp1
haploinsufﬁciency
AMPA receptors mediate fast excitatory synaptic transmission
within the CNS.44,45 Actin dynamics in spines have a major role in
coordinating the delivery and removal of AMPA receptors and the
strength of synapses.45 To address whether CYFIP1-mediated
alterations in spine morphology and actin dynamics also impinge
on the stability or mobility of AMPA receptors within synapses, we
investigated whether surface GluA2-containing receptor dynamics
were different from control in Cyﬁp1+/− neurons. Initial observa-
tions suggested that total protein levels of the AMPA receptor
subunit GluA2 are unchanged in WT and Cyﬁp1+/− neurons
(Supplementary Figures 5A and B). Therefore, we expressed pH-
sensitive superecliptic pHluorin (SEP)-tagged GluA2 in neurons to
visualize GluA2-containing synaptic clusters in dendrites. Single
GluA2SEP-containing receptors were labelled with 605 nm QDs to
follow the diffusion of individual receptors within synaptic
clusters.40 QD-labelled GluA2SEP receptors were less mobile when
inside synaptic clusters (Din = 0.023 μm
2 s− 1, Dout = 0.057 μm
2 s− 1
where D is the median diffusion coefﬁcient, Po0.0001,
Supplementary Figures 5C and D), indicating conﬁned motion at
synapses, as previously shown.46 In Cyﬁp1+/− neurons, however,
GluA2SEP-containing receptors exhibited an increased synaptic
mobility within clusters when compared with WT neurons, (WT:
Din = 0.023 μm
2 s− 1, Cyﬁp1+/−: Din = 0.034 μm
2 s− 1, Po0.01;
Figures 4i and j) as well as a reduced conﬁnement at synapses
(Supplementary Figure 5E). GluA2SEP receptor mobility outside
synapses remained unchanged between WT and Cyﬁp1+/−
neurons (WT: Dout = 0.057 μm
2 s− 1, Cyﬁp1+/−: Dout = 0.062 μm
2
s− 1, Figure 4k). These observations suggest that the restricted
mobility of GluA2 receptors at synapses is signiﬁcantly diminished
in Cyﬁp1+/− spines.
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CYFIP1 regulates neuronal development and connectivity in vivo
To conﬁrm that Cyﬁp1 haploinsufﬁciency produces similar effects
on dendritic spines in the intact animal, we investigated dendritic
complexity and spine morphology in the hippocampi of WT versus
Cyﬁp1+/− mice using Golgi staining. Cyﬁp1 haploinsufﬁciency in
postnatal day 55–60 (P55–60) animals was conﬁrmed by western
blotting (46.8% CYFIP1 protein decrease, WT control 100 ± 15.4%,
Cyﬁp1+/− 53.2 ± 7.8%, Po0.05; Supplementary Figures 3D and E).
Compared with WT male littermate controls, CA1 neurons in
Cyﬁp1+/− animals possessed a signiﬁcantly decreased dendritic
complexity within 100 μm from the soma (Figures 5a and b).
Furthermore, spine density was unchanged, but long and thin
Figure 3. Cyﬁp1 haploinsufﬁcient neurons display decreased dendritic complexity and increased immature spines. Cyﬁp1+/− hippocampal
neurons had reduced dendritic complexity compared with WT controls at 14DIV (a, b). Scale bar, 20 μm. Dendritic morphology was examined
using Sholl analysis. Cyﬁp1+/− neurons show signiﬁcantly less complex morphology as a function of distance from the soma when compared
with WT neurons (n= 18 cells per condition, *Po0.05, **Po0.01) (c). Total dendritic length (d) and total number of branch points (e) (n= 18
cells per condition, **Po0.01) are also reduced in Cyﬁp1+/− neurons compared with WT. Spine morphology was analysed at 21DIV in Cyﬁp1+/−
neurons and compared with WT cells (f, g) (upper panel: representative image; lower panel: 3-dimensional reconstruction). Scale bar, 5 μm.
Colour key for spine type in 3-dimensional reconstruction: green=mushroom, red= stubby, blue= long and thin, pink= ﬁlipodia. Cyﬁp1+/−
neurons possessed increased long, thin spines and ﬁlopodia (h) (n= 27–31 cells per condition, *Po0.05). Spine length is increased across the
entire population regardless of subtype classiﬁcation in Cyﬁp1+/− neurons compared with control neurons (i) (n=~39 000 spines per
condition, ***Po0.001).
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Figure 4. Cyﬁp1 deﬁciency affects F-actin dynamics in spines, occludes structural responses to cLTD and increases surface AMPA receptor
mobility. Cyﬁp1+/− and WT hippocampal neurons were transfected with actinGFP or LifeactGFP at 17–20DIV and subjected to FRAP live imaging
2 days later. Spines were imaged for 100 s and bleaching occurred after the ﬁrst 20 s. (a) Representative images over time in seconds of
actinGFP ﬂuorescence recovery in WT and Cyﬁp1+/− spines. The red circles highlight the bleached spine. Scale bar, 2 μm. Quantiﬁcation of GFP
ﬂuorescence intensity within the spine head region of WT compared with Cyﬁp1+/− neurons transfected with actinGFP (b) or LifeactGFP (d)
shows Cyﬁp1+/− spines recover to a greater extent than WT (data points represent an average of 25–33 movies, *Po0.05). Data are ﬁtted with
single exponentials (coloured lines). The mobile fraction, quantiﬁed as the ﬁnal amount of recovered ﬂuorescence presented as a percentage
of the total bleached ﬂuorescence, is signiﬁcantly increased in Cyﬁp1+/− neurons for both actinGFP (c) (n= 29–33, *Po0.05) and LifeactGFP (e)
(n= 24–29, *Po0.05). 21DIV WT and Cyﬁp1+/− hippocampal neurons were transfected with actinGFP and treated with either 20 μM NMDA+20
μM glycine (NMDA) or saline (SAL). (f) Representative images of spines following each treatment. Scale bar, 5 μm. Spine volume is signiﬁcantly
decreased in WT neurons following NMDA treatment compared with saline (n= 8000–13 000 spines per condition, ****Po0.0001). However,
Cyﬁp1+/− spines have basally low volumes and fail to remodel in response to NMDA (n= 12 000–14 000 spines per condition, ****Po0.0001)
(g). Spine volume is signiﬁcantly decreased in WT NMDA-treated neurons compared with saline treatment whereas Cyﬁp1+/− saline- and
NMDA-treated neurons show no leftward shift (n= 8000–14 000 spines, ****Po0.0001, one-way analysis of variance (ANOVA)) (h). GluA2SEP-
containing receptors were labelled with quantum dots (QDs) and live imaged. (i) Representative QD trajectories are shown for WT and
Cyﬁp1+/− neurons, arrowheads indicate GluA2SEP-containing synapses and green dotted line indicates synapse area. Scale bar, 2 μm.
Quantiﬁcation of receptor diffusion inside (j) and outside (k) synaptic clusters revealed that GluA2SEP-containing receptors are more mobile in
synaptic clusters of Cyﬁp1+/− neurons compared with WT (n= 140–160 QD tracks, **Po0.01). cLTD, chemical long-term depression.
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spines were increased in the apical oblique dendrites in Cyﬁp1+/−
animals (40% increase, WT: 0.56 ± 0.066 spines μm− 1, Cyﬁp1+/−:
0.79 ± 0.078 spines μm− 1, Po0.05; Figures 5c and d). These results
indicate that genetic dysregulation of Cyﬁp1 produces penetrant
effects on pyramidal neuron dendritic complexity and spine
morphology in vivo.
DISCUSSION
Altered levels of CYFIP1 are associated with several neurological
disorders including SCZ and ASD.4,5,10 However, it remains unclear
what role CYFIP1 has in the establishment or maintenance of
neuronal connectivity in the mammalian CNS, and how changes in
its expression contribute to neurological dysfunction. Here we
report that CYFIP1 regulates the maturation of neuronal dendrites
and dendritic spines, controls the availability of F-actin within
spines and impacts both spine structural plasticity and mobility of
AMPA receptors at synapses. Furthermore, modelling SCZ- and
ASD-associated Cyﬁp1 haploinsufﬁciency in mice produces deﬁcits
in dendritic complexity and spine morphology in hippocampal
pyramidal neurons in vivo.
The activity of Rho GTPases (including RhoA, Rac1 and Cdc42) is
associated with increased dendritic branch dynamics and
extension.20,21,47,48 Activation of Rac1 releases the inhibitory
action of CYFIP1 on WAVE, potentiating Arp2/3-mediated actin
polymerization suggesting that changes in CYFIP1 levels could
alter signalling events downstream of Rac1.31 Here we demon-
strate that CYFIP1 expression levels are important for dendritic
arborization and neuronal morphological complexity. Overexpres-
sion of CYFIP1 in hippocampal neurons in vitro leads to an
increase in dendritic length and complexity whereas conversely,
neurons from Cyﬁp1+/− animals have smaller, less complex
dendrites both in vitro and in vivo. Interestingly, in addition to
the effects on dendritic morphogenesis that we report here, both
WAVE1 and CYFIP1 have previously been implicated in axonal
outgrowth.49,50
A strict spatiotemporal balance between actin polymerization
and turnover, mediated by Rho GTPases, is also important for
spine formation, maturation and stability.20,21 We report that
CYFIP1 is highly enriched in dendritic spines where it co-localizes
with actin. Thus, CYFIP1 is critically placed, as a key Rac1 effector,
to locally regulate WAVE in spines, and variations in its expression
levels are likely to impact on Arp2/3-dependent spine actin
dynamics downstream of Rac1. In agreement with this, we ﬁnd
that downregulating CYFIP1 expression levels in vitro or in vivo
drives an increase in the ratio of immature-to-mature spines
suggesting that CYFIP1 is important for actin-dependent regula-
tion of spine maturation. Furthermore, we show that dendritic
spines from Cyﬁp1+/− haploinsufﬁcient neurons display enhanced
F-actin availability suggesting that spatiotemporal control over
actin polymerization is altered at Cyﬁp1+/− postsynaptic sites. A
role for CYFIP1 in the regulation of Rac1-dependent F-actin
assembly in Drosophila NMJ presynaptic terminals was also
recently demonstrated, where it was shown to be important for
synaptogenesis and presynaptic quantal content.51,52 In addition
to previous functions described for CYFIP1 in the regulation of
mRNA translation in dendrites and mGluR-long-term depression,
our results suggest that CYFIP1 also has a vital role in the local
regulation of spine actin dynamics via WAVE and Arp2/3.32,35 This
is in agreement with a recent study showing that CYFIP1
Figure 5. Cyﬁp1 haploinsufﬁciency in vivo decreases dendritic complexity and increases the number of immature dendritic spines. Golgi-
stained CA1 neurons from Cyﬁp1+/− and WT littermate controls (P55–60) were traced to analyse dendritic morphology and spines. Example
traces of Cyﬁp1+/− and WT neurons (a). Sholl analysis indicates that Cyﬁp1+/− neurons are less complex within 100 μm from the soma, in both
apical and basal compartments, compared with WT control neurons (n= 9–12 cells per condition, *Po0.05, **Po0.01) (b). Analysis of
dendritic spine density reveals no change in total spine density but a signiﬁcant increase in immature long, thin spines in Cyﬁp1+/− neurons
compared with WT control (n= 12 cells per condition, *Po0.05) (c, d).
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translocates between the FMRP-containing protein synthesis
machinery and the actin-regulatory complex, and that disrupting
CYFIP1’s interaction with members of either complex negatively
impacted spine maturation in neurons.34
The surface mobility of neurotransmitter receptors is dynami-
cally regulated to control synaptic activity and is emerging as
another key component underlying plasticity at nerve
terminals.40,53,54 The trapping of mobile AMPA receptors within
the postsynaptic domain is thought to be critical for maintaining
and strengthening synaptic communication, and a pathological
impairment in this process could have signiﬁcant implications for
neurotransmission.55 The enrichment of CYFIP1 at excitatory
synapses implies that CYFIP1 can locally regulate actin cytoskeletal
dynamics in the postsynaptic domain. This ﬁne-tuning of actin
turnover has previously been demonstrated to be an important
regulator of synaptic glutamate receptor mobility. Indeed, we ﬁnd
that the disruption of spine maturation due to decreased CYFIP1
levels also correlates with an increase in AMPA receptor mobility
within the spine postsynaptic density. Consequently, CYFIP1
expression levels appear to be critical not just for the maturation
of dendritic spines but may also be important for regulating the
subsynaptic cytoskeletal architecture essential for the stabilization
of postsynaptic AMPA receptors.
Dynamic regulation of F-actin assembly is repeatedly implicated
in mechanisms underlying spine structural plasticity.21,56–61 We
observe that NMDA receptor-induced spine remodelling no longer
occurs in Cyﬁp1+/− neurons, suggesting that when CYFIP1 levels
are reduced, F-actin assembly is basally overactive and cannot
induce further spine remodelling in response to NMDA. CYFIP1
has been previously shown to couple local actin polymerization to
membrane budding at subcellular compartments such as the
trans-Golgi network.33,62 Therefore, it will be interesting in the
future to determine if the coupling of activity-dependent AMPA
receptor trafﬁcking (e.g., at the Golgi or in the endocytic network)
to alterations in spine volume is also disrupted upon CYFIP1
depletion.63
Our results suggest that CYFIP1 is part of a growing number of
mental illness-associated actin-regulatory molecules, including
DISC1, DTNBP1, SHANK3, SRGAP2, Oligophrenin and the Abi1-
WAVE2 complex that act in Rac1-dependent pathways to regulate
dendritic development and spine dynamics.24–29 As we observe an
increase in immature spines upon CYFIP1 overexpression or
haploinsufﬁciency in vitro, it is interesting to note that several
other proteins known to signal via actin-regulatory pathways have
been shown to drive similar effects on spine structure when either
up- or downregulated, including VCP/neuroﬁbromin, NESH/Abi-3
and Coﬁlin.47,48,57,64–67 Thus, the precise tuning of CYFIP1
expression levels may be crucial for stabilising synaptic contacts,
and skewing its levels above or below a critical threshold may
force spines into a structurally unstable state. This may explain
why both deletions and duplications of CYFIP1 have been linked
to major mental illness.
Recent work has highlighted that rare complete gene knockouts
in humans have a signiﬁcant role in ASD and major mental
illness.68 Although both deletions and duplications of CYFIP1 have
been identiﬁed, total loss of CYFIP1 in humans seems unlikely as
we report here that complete CYFIP1 deletion in mice leads to a
failure in early embryonic development with Cyﬁp1-null embryos
unable to survive beyond E8.5. Similar developmental abnormal-
ities, resulting in death during early embryogenesis, have been
observed in mice lacking other critical actin-regulatory genes such
as Rac1 and the WAVE complex component Nap1. Deletion of
these genes in the mouse cause death during gastrulation at E7.5
and E9, respectively.69–71 Therefore, throughout early mouse
development, CYFIP1 signalling events, probably via its core
conserved actin-regulatory functions, are likely critical for gas-
trulation and normal patterning of embryonic structure in addition
to later roles in neuronal development and plasticity.72 The
embryonic lethality observed in the CYFIP1 knockout suggests
that CYFIP2 cannot compensate for all CYFIP1 functions. Intrigu-
ingly, we also observed CYFIP2 to be enriched in dendritic spines
and its overexpression could drive increased dendritogenesis. This
suggests that it will be interesting to further explore whether
CYFIP2 is a candidate susceptibility gene for major mental illness.
Our results provide important new insights into the role CYFIP1
has in the development of the nervous system and how Cyﬁp1
dysregulation can alter CNS function to contribute to the
development of neuropsychiatric illness. Changes in the structure
and function of excitatory synapses, and alterations in the local
versus long-range dendritic connectivity of neurons, have both
been associated with the development of neuropsychiatric
conditions involving imbalances of excitation and inhibition, such
as ASD and SCZ.73,74 The roles for CYFIP1 described here may help
inform how altered levels of this molecule gives rise to network-
level dysfunction that deﬁne these pathologies.
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